Phase 2 Uterine Cancer Clinical Trials
7 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–7 of 7 trials
Recruiting
Phase 2
PROton Therapy for Post Surgical Treatment of GYNecologic Cancer
Cervical CancerEndometrial CancerUterine Cancer
Abramson Cancer Center at Penn Medicine25 enrolled3 locationsNCT05758688
Recruiting
Phase 1Phase 2
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Triple-Negative Breast CancerEndometrial CancerPrimary Peritoneal Carcinoma+12 more
Genmab764 enrolled67 locationsNCT05579366
Recruiting
Phase 2
Azenosertib in Uterine Serous Carcinoma: Biomarker Study
Uterine CancerUterine Serous CarcinomaUterine Carcinoma
Joyce Liu, MD25 enrolled2 locationsNCT06369155
Recruiting
Phase 2
Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin
Ovarian CancerCervical CancerEndometrial Cancer+5 more
Dana-Farber Cancer Institute32 enrolled2 locationsNCT06677190
Recruiting
Phase 2
[18F]FES PET/.CT in Uterine Cancer
Uterine Cancer
Abramson Cancer Center at Penn Medicine30 enrolled1 locationNCT05916196
Recruiting
Phase 1Phase 2
Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
Endometrial CancerCarcinomaGynecologic Cancer+1 more
University of Alabama at Birmingham37 enrolled1 locationNCT05559879
Recruiting
Phase 1Phase 2
Study of NEO-201 in Solid Tumors Expansion Cohorts
Cervical CancerNon-small Cell Lung CancerHead and Neck Squamous Cell Carcinoma+1 more
Precision Biologics, Inc121 enrolled2 locationsNCT03476681